--2024/Q4-- / 259.000M--
Nov 6, 20242024/Q3293.800M / 297.500M--
Aug 6, 20242024/Q2254.700M / 190.000M--
May 1, 20242024/Q1300.400M / 220.250M--
Mar 6, 20242023/Q4276.600M / 274.000M--
US Stock MarketDetailed Quotes
EBS Emergent BioSolutions
- 9.960
- +0.480+5.06%
Trading Nov 25 15:41 ET
539.67MMarket Cap-2547P/E (TTM)
10.140High9.450Low853.23KVolume9.540Open9.480Pre Close8.45MTurnover1.61%Turnover RatioLossP/E (Static)54.18MShares15.10052wk High1.06P/B528.64MFloat Cap1.42052wk Low--Dividend TTM53.08MShs Float137.610Historical High--Div YieldTTM7.28%Amplitude1.420Historical Low9.900Avg Price1Lot Size
Emergent BioSolutions Key Stats
Emergent BioSolutions Q3 2024 Earnings Date
Currency：USDNov 6, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 297.50M | 293.80M | -3.70M |
| Miss Est. | +9.98% | +8.61% | -1.24% |
| EPS | -0.31 | 2.06 | +2.37 |
| Beat Est. | +93.82% | +140.55% | +756.05% |
Analyst Rating
Nov 22, 2024
Emergent BioSolutions Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Emergent BioSolutions Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
